08-08-2024 |
AH |
|
BLFS |
BioLife Solutions, Inc. |
1,050 |
-0.06 |
-0.14 |
-0.24 |
BioLife Solutions GAAP EPS of -$0.50 misses by $0.36, revenue of $28.3M beats by $4.35M [8/8/2024 4:07 PM] |
25.11 |
2.37 (10.40%) |
22.74 |
0.0 (0.00%) |
8.92 - 25.72 |
873,115 |
340,000 |
8,657 |
|
|
09-05-2024 |
AH |
|
BLFS |
BioLife Solutions, Inc. |
842.58 |
-0.19 |
-0.25 |
-0.27 |
BioLife Solutions GAAP EPS of -$0.22, revenue of $31.7M [5/9/2024 4:35 PM] |
19.51 |
1.50 (8.33%) |
18.01 |
0.0 (0.00%) |
8.92 - 24.50 |
1,570,535 |
420,000 |
11,456 |
|
|
29-02-2024 |
AH |
|
BLFS |
BioLife Solutions, Inc. |
774.95 |
-0.22 |
-0.24 |
-0.19 |
BioLife Solutions GAAP EPS of -$0.30 beats by $0.04, revenue of $32.73M misses by $0.15M [2/29/2024 4:29 PM] |
17.98 |
1.08 (6.39%) |
15.50 |
-1.40 (-8.28%) |
8.92 - 24.50 |
912,357 |
340,000 |
814 |
|
|
09-11-2023 |
AH |
|
BLFS |
BioLife Solutions, Inc. |
504.05 |
-0.34 |
-0.25 |
-0.15 |
BioLife Solutions GAAP EPS of -$0.67 misses by $0.29, revenue of $33.3M in-line [11/9/2023 4:09 PM] |
11.00 |
-0.39 (-3.42%) |
11.39 |
0.0 (0.00%) |
8.92 - 26.89 |
838,907 |
500,000 |
3,922 |
|
|
08-08-2023 |
AH |
|
BLFS |
BioLife Solutions, Inc. |
835.23 |
-0.24 |
-0.02 |
-0.13 |
BioLife Solutions GAAP EPS of -$0.23 misses by $0.02, revenue of $39.51M misses by $3.82M [8/8/2023 4:39 PM] |
13.11 |
-5.29 (-28.74%) |
16.99 |
-1.40 (-7.61%) |
12.79 - 26.96 |
2,186,254 |
280,000 |
1,451 |
|
|
10-05-2023 |
AH |
4:05 PM ET (May 10) |
BLFS |
BioLife Solutions, Inc. |
827.94 |
-0.27 |
-0.10 |
-0.19 |
BioLife Solutions GAAP EPS of -$0.32 misses by $0.11, revenue of $37.7M misses by $5.24M [5/10/2023 4:23 PM] |
18.23 |
-0.38 (-2.07%) |
17.90 |
-0.71 (-3.82%) |
10.40 - 26.96 |
825,440 |
220,000 |
12,073 |
|
|
16-03-2023 |
AH |
4:05 PM ET (Mar 16) |
BLFS |
BioLife Solutions, Inc. |
959.67 |
-0.19 |
-0.16 |
-0.32 |
BioLife Solutions GAAP EPS of -$1.15 misses by $0.99, revenue of $44.26M beats by $0.94M [3/16/2023 4:04 PM] |
21.41 |
1.43 (7.16%) |
19.93 |
-0.05 (-0.25%) |
10.40 - 26.96 |
487,431 |
380,000 |
2,603 |
|
|
09-11-2022 |
AH |
4:05 PM ET (Nov 9) |
BLFS |
BioLife Solutions, Inc. |
818.69 |
-0.15 |
-0.12 |
-0.19 |
BioLife Solutions GAAP EPS of -$0.23 misses by $0.06, revenue of $40.7M misses by $1.36M [11/9/2022 4:20 PM] |
24.65 |
7.35 (42.49%) |
17.30 |
0.0 (0.00%) |
10.40 - 53.35 |
1,174,881 |
520,000 |
2,993 |
|
|
09-08-2022 |
AH |
4:00 PM ET (Aug 9) |
BLFS |
BioLife Solutions, Inc. |
752.35 |
-0.13 |
-0.19 |
0.00 |
BioLife Solutions GAAP EPS of -$1.71 misses by $1.50, revenue of $40.5M beats by $1.33M [8/9/2022 4:28 PM] |
24.12 |
3.78 (18.55%) |
20.00 |
-0.35 (-1.72%) |
10.40 - 60.67 |
663,877 |
310,000 |
348 |
|
|
09-05-2022 |
AH |
4:00 PM ET (May 9) |
BLFS |
BioLife Solutions, Inc. |
525.77 |
-0.19 |
-0.13 |
0.01 |
BioLife Solutions GAAP EPS of -$0.17 beats by $0.09, revenue of $36.22M misses by $1.98M [5/9/2022 4:11 PM] |
12.05 |
1.15 (10.55%) |
10.90 |
0.0 (0.00%) |
10.74 - 60.67 |
611,667 |
404,228 |
474 |
|
|
28-02-2022 |
AH |
4:05 PM ET (Feb 28) |
BLFS |
BioLife Solutions, Inc. |
984.12 |
-0.32 |
-0.07 |
-0.01 |
BioLife Solutions GAAP EPS of -$0.37 misses by $0.20, revenue of $37.3M beats by $0.87M [2/28/2022 4:19 PM] |
23.65 |
0.15 (0.64%) |
23.50 |
0.0 (0.00%) |
20.25 - 60.67 |
503,718 |
350,000 |
47,555 |
|
|
11-11-2021 |
AH |
4:05 PM ET (Nov 11) |
BLFS |
BioLife Solutions, Inc. |
2,210 |
-0.19 |
0.02 |
-0.02 |
BioLife Solutions EPS beats by $0.09, beats on revenue [11/11/2021 4:36 PM] |
46.65 |
-2.15 (-4.41%) |
48.00 |
-0.80 (-1.64%) |
28.15 - 60.67 |
555,949 |
410,000 |
105 |
|
|
12-08-2021 |
AH |
4:05 PM ET (Aug 12) |
BLFS |
BioLife Solutions, Inc. |
1,970 |
N/A |
0.03 |
-0.01 |
BioLife Solutions EPS misses by $0.03, beats on revenue [8/12/2021 4:16 PM] |
45.21 |
-2.85 (-5.92%) |
48.75 |
0.69 (1.44%) |
18.22 - 50.45 |
320,560 |
130,000 |
100 |
|
|
13-05-2021 |
AH |
4:05 PM ET (May 13) |
BLFS |
BioLife Solutions, Inc. |
1,070 |
0.01 |
-0.01 |
0.06 |
BioLife Solutions EPS beats by $0.01, beats on revenue [5/13/2021 4:27 PM] |
29.77 |
0.24 (0.81%) |
29.00 |
-0.53 (-1.79%) |
13.76 - 47.97 |
576,186 |
290,000 |
3,336 |
|
|
22-03-2021 |
AH |
4:05 PM ET (Mar 22) |
BLFS |
BioLife Solutions, Inc. |
1,220 |
-0.01 |
-0.02 |
0.00 |
BioLife Solutions EPS misses by $0.01, beats on revenue [3/22/2021 4:11 PM] |
41.90 |
3.33 (8.63%) |
46.43 |
7.86 (20.38%) |
8.29 - 47.97 |
1,778,190 |
260,000 |
26,909 |
|
-
BioLife Solutions EPS misses by $0.01, beats on revenue [3/22/2021 4:11 PM]
-
BioLife Solutions stock scales 10% on acquisition of Stirling Ultracold [3/22/2021 4:16 PM]
-
Ionis viewed favorably despite trial setback; BioLife Solutions upgraded at Benchmark in today’s analyst action [3/23/2021 8:04 AM]
-
Earnings Preview for BioLife Solutions [Mar-19-21 10:44AM]
-
BioLife Solutions, Inc. to Host Earnings Call [Mar-22-21 02:30PM]
-
Stirling Ultracold Announces Merger Agreement with BioLife Solutions to Further Support Life-Science Industry with Expertise in Ultra-Low Temperature Storage [Mar-22-21 04:05PM]
-
BioLife Solutions Announces Fourth Quarter and Full Year 2020 Financial Results [Mar-22-21 04:05PM]
-
BioLife Solutions to Acquire Stirling Ultracold in an All-Stock Merger [Mar-22-21 04:03PM]
-
Stirling Ultracold to Merge with BioLife Solutions, the Leader in Gene and Cell Therapy Bioproduction Tools and Services [Mar-22-21 05:00PM]
-
BioLife Solutions, Inc. (BLFS) Reports Q4 Loss, Tops Revenue Estimates [Mar-22-21 05:25PM]
-
BioLife Solutions: Q4 Earnings Insights [Mar-22-21 05:44PM]
-
Biolife Solutions Inc (BLFS) Q4 2020 Earnings Call Transcript [Mar-23-21 12:00AM]
-
BioLife Solutions Rises 17% On Stronger-Than-expected FY21 Revenue Outlook [Mar-23-21 04:45AM]
-
The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO [Mar-23-21 08:18AM]
-
Analysts Upgrade BioLife After Stirling Acquisition, Revenue Jump [Mar-23-21 07:54AM]
-
5 Top Stock Gainers for Tuesday: Dolphin Entertainment, Benitec, BioLife [Mar-23-21 09:25AM]
-
5 Top Stock Gainers for Tuesday: Dolphin Entertainment, Benitec [Mar-23-21 12:18PM]
|
05-11-2020 |
AH |
4:05 PM ET (Nov 5) |
BLFS |
BioLife Solutions, Inc. |
1,000.00 |
-0.02 |
-0.02 |
0.01 |
BioLife Solutions EPS in-line, beats on revenue, withdaws FY20 guidance [11/5/2020 5:11 PM] |
33.86 |
2.48 (7.88%) |
30.99 |
-0.40 (-1.27%) |
7.37 - 35.17 |
483,048 |
313,606 |
1,201 |
|
|
06-08-2020 |
AH |
4:05 PM ET (Aug 6) |
BLFS |
BioLife Solutions, Inc. |
670.93 |
-0.01 |
0.00 |
0.04 |
BioLife Solutions EPS misses by $0.67, beats on revenue [8/6/2020 4:29 PM] |
21.37 |
0.70 (3.37%) |
20.85 |
0.18 (0.87%) |
7.37 - 22.25 |
193,411 |
202,191 |
1,713 |
|
|
14-05-2020 |
AH |
4:30 PM ET (May 14) |
BLFS |
BioLife Solutions, Inc. |
311.49 |
0.06 |
0.00 |
0.03 |
BioLife Solutions EPS beats by $0.02, beats on revenue [5/14/2020 4:07 PM] |
15.35 |
0.78 (5.35%) |
15.35 |
0.0 (0.00%) |
7.37 - 21.18 |
514,494 |
211,782 |
6,238 |
|
|